Thermo Fisher Scientific Analytical Instruments — Operating Income (Loss) decreased by 4.9% to $429.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from $451.00M to $429.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved operational efficiency or higher sales volume, while a decrease indicates margin pressure or rising costs.
The profit or loss generated by the Analytical Instruments segment after deducting all operating expenses from total rev...
The primary benchmark for comparing the operational performance of business segments across the industry.
tmo_segment_analytical_instruments_operating_income_loss| Q2 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $280.00M | $301.00M | $344.00M | $477.00M | $477.00M | $477.00M | $477.00M | $451.00M | $429.00M |
| QoQ Change | — | +7.5% | +14.3% | +38.7% | +0.0% | +0.0% | +0.0% | -5.5% | -4.9% |
| YoY Change | — | — | +22.9% | +58.5% | +38.7% | — | — | -5.5% | -4.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.